SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)

Italy flag Italy · Delayed Price · Currency is EUR
15.80
0.00 (0.00%)
At close: Feb 9, 2026
Market Cap2.21B -36.5%
Revenue (ttm)995.03M +4.2%
Net Income149.95M +11.8%
EPS0.99 +11.3%
Shares Outn/a
PE Ratio14.77
Forward PE15.02
Dividend0.18 (1.28%)
Ex-Dividend DateFeb 4, 2026
Volumen/a
Average Volume3
Open15.80
Previous Close15.80
Day's Range15.80 - 15.80
52-Week Range13.96 - 30.40
Betan/a
RSI37.92
Earnings DateFeb 11, 2026

About BIT:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application... [Read more]

Industry Glass Containers
Founded 1884
Employees 4,811
Stock Exchange Borsa Italiana
Ticker Symbol 1SXP
Full Company Profile

Financial Performance

In fiscal year 2025, BIT:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements